Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Top Cited Papers
- 3 April 2008
- Vol. 336 (7651) , 999-1003
- https://doi.org/10.1136/bmj.39524.439618.25
Abstract
Objective To investigate whether placebo effects can experimentally be separated into the response to three components—assessment and observation, a therapeutic ritual (placebo treatment), and a supportive patient-practitioner relationship—and then progressively combined to produce incremental clinical improvement in patients with irritable bowel syndrome. To assess the relative magnitude of these components. Design A six week single blind three arm randomised controlled trial. Setting Academic medical centre. Participants 262 adults (76% women), mean (SD) age 39 (14), diagnosed by Rome II criteria for and with a score of ≥150 on the symptom severity scale. Interventions For three weeks either waiting list (observation), placebo acupuncture alone (“limited”), or placebo acupuncture with a patient-practitioner relationship augmented by warmth, attention, and confidence (“augmented”). At three weeks, half of the patients were randomly assigned to continue in their originally assigned group for an additional three weeks. Main outcome measures Global improvement scale (range 1-7), adequate relief of symptoms, symptom severity score, and quality of life. Results At three weeks, scores on the global improvement scale were 3.8 (SD 1.0) v 4.3 (SD 1.4) v 5.0 (SD 1.3) for waiting list versus “limited” versus “augmented,” respectively (Pv 42 (67) v 82 (89), Pv 4.1 (9.4) v 9.3 (14.0), PConclusion Factors contributing to the placebo effect can be progressively combined in a manner resembling a graded dose escalation of component parts. Non-specific effects can produce statistically and clinically significant outcomes and the patient-practitioner relationship is the most robust component. Trial registration Clinical Trials NCT00065403.Keywords
This publication has 32 references indexed in Scilit:
- The power of context: reconceptualizing the placebo effectJournal of the Royal Society of Medicine, 2008
- Functional Bowel DisordersGastroenterology, 2006
- Personal view: adequate relief as a primary endpoint in irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2006
- Neurobiological Mechanisms of the Placebo EffectJournal of Neuroscience, 2005
- The placebo effect in irritable bowel syndrome trials: a meta‐analysis1Neurogastroenterology & Motility, 2005
- Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsiaGut, 2004
- The economic impact of irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2003
- Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).Gastroenterology, 2003
- Harnessing placebo effects in health careThe Lancet, 1994
- Treatment fidelity in outcome studiesClinical Psychology Review, 1991